HSP27 expression was reported to involve chemotherapy resistance, and our results also suggest that a combination of cisplatin with HSP27 cross-linkers produced synergistic sensitization to NSCLC in EGFR-WT. Here, HSPB1 is linked to non-small cell lung carcinoma.